Acalabrutinib (ACP-196) in relapsed chronic lymphocytic leukemia JC Byrd, B Harrington, S O’Brien, JA Jones, A Schuh, S Devereux, ... New England Journal of Medicine 374 (4), 323-332, 2016 | 1040 | 2016 |
Etiology of ibrutinib therapy discontinuation and outcomes in patients with chronic lymphocytic leukemia KJ Maddocks, AS Ruppert, G Lozanski, NA Heerema, W Zhao, L Abruzzo, ... JAMA oncology 1 (1), 80-87, 2015 | 658 | 2015 |
BTKC481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia JA Woyach, AS Ruppert, D Guinn, A Lehman, JS Blachly, A Lozanski, ... Journal of Clinical Oncology 35 (13), 1437-1443, 2017 | 515 | 2017 |
Efficacy and safety of midostaurin in advanced systemic mastocytosis J Gotlib, HC Kluin-Nelemans, TI George, C Akin, K Sotlar, O Hermine, ... New England Journal of Medicine 374 (26), 2530-2541, 2016 | 508 | 2016 |
Ibrutinib treatment improves T cell number and function in CLL patients M Long, K Beckwith, P Do, BL Mundy, A Gordon, AM Lehman, ... The Journal of clinical investigation 127 (8), 3052-3064, 2017 | 363 | 2017 |
Hypertension and incident cardiovascular events following ibrutinib initiation T Dickerson, T Wiczer, A Waller, J Philippon, K Porter, D Haddad, A Guha, ... Blood, the Journal of the American Society of Hematology 134 (22), 1919-1928, 2019 | 219 | 2019 |
Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial JA Jones, T Robak, JR Brown, FT Awan, X Badoux, S Coutre, ... The Lancet Haematology 4 (3), e114-e126, 2017 | 218 | 2017 |
Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib FT Awan, A Schuh, JR Brown, RR Furman, JM Pagel, P Hillmen, ... Blood advances 3 (9), 1553-1562, 2019 | 206 | 2019 |
Wnt'er in liver: expression of Wnt and frizzled genes in mouse G Zeng, F Awan, W Otruba, P Muller, U Apte, X Tan, C Gandhi, ... Hepatology 45 (1), 195-204, 2007 | 192 | 2007 |
Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results JC Byrd, WG Wierda, A Schuh, S Devereux, JM Chaves, JR Brown, ... Blood, The Journal of the American Society of Hematology 135 (15), 1204-1213, 2020 | 187 | 2020 |
Higher doses of lenalidomide are associated with unacceptable toxicity including life-threatening tumor flare in patients with chronic lymphocytic leukemia LA Andritsos, AJ Johnson, G Lozanski, W Blum, C Kefauver, F Awan, ... Journal of Clinical Oncology 26 (15), 2519-2525, 2008 | 177 | 2008 |
Use of chimeric antigen receptor T cell therapy in clinical practice for relapsed/refractory aggressive B cell non-Hodgkin lymphoma: an expert panel opinion from the American … T Jain, M Bar, AJ Kansagra, EA Chong, SK Hashmi, SS Neelapu, M Byrne, ... Biology of Blood and Marrow Transplantation 25 (12), 2305-2321, 2019 | 174 | 2019 |
Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinib TE Wiczer, LB Levine, J Brumbaugh, J Coggins, Q Zhao, AS Ruppert, ... Blood advances 1 (20), 1739-1748, 2017 | 163 | 2017 |
Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemia EM McWilliams, JM Mele, C Cheney, EA Timmerman, F Fiazuddin, ... Oncoimmunology 5 (10), e1226720, 2016 | 154 | 2016 |
The BTK inhibitor ARQ 531 targets ibrutinib-resistant CLL and Richter transformation SD Reiff, R Mantel, LL Smith, JT Greene, EM Muhowski, CA Fabian, ... Cancer discovery 8 (10), 1300-1315, 2018 | 153 | 2018 |
CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain–engineered monoclonal antibody FT Awan, R Lapalombella, R Trotta, JP Butchar, B Yu, DM Benson Jr, ... Blood, The Journal of the American Society of Hematology 115 (6), 1204-1213, 2010 | 150 | 2010 |
Clinical practice recommendations for use of allogeneic hematopoietic cell transplantation in chronic lymphocytic leukemia on behalf of the Guidelines Committee of the American … MA Kharfan-Dabaja, A Kumar, M Hamadani, S Stilgenbauer, P Ghia, ... Biology of Blood and Marrow Transplantation 22 (12), 2117-2125, 2016 | 121 | 2016 |
Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia L Pei, JH Choi, J Liu, EJ Lee, B McCarthy, JM Wilson, E Speir, F Awan, ... Epigenetics 7 (6), 567-578, 2012 | 120 | 2012 |
Phase 1b study of obinutuzumab, ibrutinib, and venetoclax in relapsed and refractory chronic lymphocytic leukemia KA Rogers, Y Huang, AS Ruppert, FT Awan, NA Heerema, C Hoffman, ... Blood, The Journal of the American Society of Hematology 132 (15), 1568-1572, 2018 | 104 | 2018 |
Ventricular arrhythmias following ibrutinib initiation for lymphoid malignancies A Guha, MH Derbala, Q Zhao, TE Wiczer, JA Woyach, JC Byrd, FT Awan, ... Journal of the American College of Cardiology 72 (6), 697-698, 2018 | 103 | 2018 |